![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/alchemab-advances-a-novel-antibody-with-potential-in-parkinsons-disease-with-support-from-the-michael-j-fox-foundation-302165114.html
https://www.pharmiweb.com/press-release/2024-05-15/publication-in-nature-immunology-outlining-the-contribution-of-b-cells-to-anticancer-immunosurveillance-highlights-alchemab-s-capabilities-and-potenti
https://www.prnewswire.com/news-releases/alchemab-therapeutics-unveils-alzheimers-candidate-atlx-1088-targeting-cd33-at-the-antibody-industrial-symposium-301857675.html
https://www.fiercebiotech.com/biotech/alchemab-s-new-well-connected-ceo-will-lead-biotech-journey-to-address-hard-to-treat